Atrial fibrillation: selecting patients at risk for cardiovascular events by blood pressure-Reference-Cited by-同舟云学术

Atrial fibrillation: selecting patients at risk for cardiovascular events by blood pressure

Published:2020-11-09 Issue:48 Volume:41 Page:4600-4600
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Millenaar Dominic¹^ORCID,Böhm Michael¹

Affiliation:

1. Department of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Kirrberger Str. 1, IMED, building 41, 66421 Homburg/Saar, Germany

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/41/48/4600/35329270/ehaa774.pdf

Reference5 articles.

1. Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial;Böhm;Eur Heart J,2020

2. Research in atrial fibrillation: a scientometric analysis using the novel web application SciPE. JACC Clin Electrophysiol;Millenaar;Volume,2020

3. Efficacy of empagliflozin on heart failure and renal outcomes in patients with atrial fibrillation: data from the EMPA-REG OUTCOME trial;Böhm;Eur J Heart Fail,2020

4. Atrial fibrillation, an equivalent of cardiovascular disease risk

5. 2018 ESC/ESH Guidelines for the management of arterial hypertension;Williams;Eur Heart J,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focus on hypertension but also on the ‘the digital twin’ and on kidney function and disease;European Heart Journal;2020-12-21